Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement.
Across FY2010–FY2026: $222.7M in buybacks, $149.54M in dividends.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
Term Loan
TermLoan · Standex International Corporation
Reference: Term Loan
Past stated maturity
Original principal
USD 250,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Oct 27, 2025
Last reported interest terms:
Standex will pay a variable rate of interest. As time goes on, the variable rate charge will increase.
Reported 2024-10-31Later filings may not restate these terms; this does not confirm they still apply.
Covenant terms for this agreement are not yet verified.
On October 28, 2024, Standex entered into a Credit Agreement (the “Term Loan Credit Agreement”) by and among Citizens Bank, N.A., as administrative agent, lead arranger and book runner, each of the lenders party thereto from time to time (the “Term Loan Lenders”) and Standex**.** Pursuant to the terms of the Credit Agreement, the Term Loan Lenders advanced to Standex a $250,000,000 term loan (the “Term Loan”). The Term Loan Funds were used to fund a portion of the Amran Transaction and the Narayan Transaction.
Issuer evidence: On October 28, 2024 (the “Closing Date”), Standex International Corporation, a Delaware corporation (“Standex”), acquired Amran, LLC, a Texas limited liability company (“Amran”), pursuant to a Securities Purchase Agreement dated as of the Closing Date (the “Amran Purchase Agreement”) by and among Standex, Amran, the parties listed as “Owners” therein, Bolt Founders, Inc. (“Bolt”) and the Seller Representative (as defined therein) (the “Amran Transaction”). Pursuant to the Amran Purchase Agreement, on the Closing Date, Standex acquired 100% of the outstanding membership interests of Amran from Bolt, in consideration for an aggregate of $180,600,000 (the “Amran Consideration”). The Amran Consideration consisted of $153,510,000 paid in cash in consideration for 85% of the outstanding membership interests of Amran and 152,299 shares of Standex common stock (the “Amran Issued Securities”) for the remaining 15% of the outstanding membership interests of Amran, reflecting the equivalent of $27,090,000, divided by $177.87 (the “Closing Price”), being the volume weighted average price of Standex’s common stock measured over a 30-day trading period preceding the Closing Date. The Amran Issued Securities were not registered under the Securities Act of 1933, as amended (the “Securities Act”). Standex issued the Amran Issued Securities to Bolt, an “accredited investor” as defined in Regulation D promulgated under the Securities Act, in a transaction exempt from registration under the Securities Act pursuant to Section 4(a)(2) of the Securities Act. The Amran Purchase Agreement contains certain restrictions on the sale of the Amran Issued Securities during the first three years after the Closing Date.
Supporting evidence: Under the terms of the Term Loan Credit Agreement, Standex will pay a variable rate of interest. As time goes on, the variable rate charge will increase. The Term Loan may be in the form of either Alternate Base Rate or Term SOFR loans. The rate of interest on Alternate Base Rate loans shall be the higher of (i) the Federal Funds rate plus ½ of 1%, (ii) the “prime rate” announced by Citizens Bank, N. A. or (iii) the daily SOFR Rate on such day plus 1%, plus an additional amount based upon the time period. The rate of interest on SOFR Rate loans shall be the Term SOFR Reference Rate plus 0.1% rate which corresponds to a one month interest period, plus an additional amount based upon the time period.
Supporting evidence: The Term Loan matures on October 27, 2025, and contains customary representations, warranties and restrictive covenants, each of which are substantially similar to such representations, warranties and covenants contained in the Revolving Credit Agreement (as defined below).
Supporting evidence: On October 28, 2024, Standex entered into a Credit Agreement (the “Term Loan Credit Agreement”) by and among Citizens Bank, N.A., as administrative agent, lead arranger and book runner, each of the lenders party thereto from time to time (the “Term Loan Lenders”) and Standex**.** Pursuant to the terms of the Credit Agreement, the Term Loan Lenders advanced to Standex a $250,000,000 term loan (the “Term Loan”). The Term Loan Funds were used to fund a portion of the Amran Transaction and the Narayan Transaction.
Supporting evidence: On October 28, 2024, Standex entered into a Credit Agreement (the “Term Loan Credit Agreement”) by and among Citizens Bank, N.A., as administrative agent, lead arranger and book runner, each of the lenders party thereto from time to time (the “Term Loan Lenders”) and Standex**.** Pursuant to the terms of the Credit Agreement, the Term Loan Lenders advanced to Standex a $250,000,000 term loan (the “Term Loan”). The Term Loan Funds were used to fund a portion of the Amran Transaction and the Narayan Transaction.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
3.55×
Peer median 2.79×
EV/EBIT
15.74×
Peer median 19.94×
P/E (TTM)
24.75×
Peer median 27.27×
Price/Sales (TTM)
3.11×
Peer median 2.58×
Price/Book
3.62×
Peer median 3.39×
EV/Adj. EBITDA (FY2026)
16.56×
Peer median 15.55×
Peer medians compare against the 44 similar-size Specialty Industrial Machinery companies (of 85 listed).
EV/Adj. EBITDA uses
the company-stated
“Adjusted EBITDA”,
extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.
Valuation over time computed as of each quarter's filing date
EV/Adj. EBITDA uses
the company-stated
“Adjusted EBITDA”,
extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
Component
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Electronics Products Group
$475,036,000
$400,130,000
$321,956,000
$305,872,000
$304,290,000
$253,369,000
$185,294,000
$204,073,000
Engraving Group
$182,329,000
$179,303,000
$206,034,000
$152,067,000
$146,255,000
$147,016,000
$143,736,000
$149,693,000
Aerospace and Defense
$135,031,000
$102,595,000
$83,476,000
$81,079,000
$78,117,000
$75,562,000
$104,047,000
$105,270,000
Scientific Group
$75,748,000
$72,380,000
$68,931,000
$74,924,000
$83,850,000
$79,421,000
$57,523,000
$57,621,000
All Other Segments
$23,453,000
$35,699,000
$40,238,000
—
—
—
—
—
Specialty Solutions Group
—
$86,642,000
$95,587,000
$127,106,000
$122,827,000
$100,864,000
$113,935,000
$123,274,000
Corporate And Other
—
—
$0
$0
$0
$0
$0
$0
By Geography (USD)
Component
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
United States
$520,745,000
$467,339,000
$444,373,000
$449,820,000
$429,368,000
$386,829,000
$364,188,000
$370,235,000
Asia Pacific
$233,343,000
$194,035,000
$130,423,000
$130,130,000
$148,028,000
$125,516,000
$98,665,000
$108,667,000
EMEA
$128,876,000
$119,610,000
$132,306,000
$144,672,000
$143,967,000
$129,908,000
$128,037,000
$144,636,000
Other Americas
$8,633,000
$9,123,000
$13,533,000
$16,426,000
$13,976,000
$13,979,000
$13,645,000
$16,393,000
By Product & Service (USD)
Component
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Engraving Services
$125,244,000
$116,777,000
$140,591,000
$145,616,000
$136,779,000
$137,159,000
$132,586,000
$139,769,000
Scientific Products and Services
$75,748,000
$72,380,000
$68,931,000
$74,924,000
$83,850,000
$79,421,000
$57,523,000
$57,621,000
Hydraulics Cylinders and System
$46,070,000
$50,943,000
$110,698,000
$122,020,000
$109,728,000
$48,776,000
$51,722,000
$53,943,000
Engraving Products
$11,015,000
$11,583,000
$10,094,000
$6,451,000
$9,476,000
$9,857,000
$11,150,000
$9,924,000
Engineering Technologies Components
—
$102,595,000
$83,476,000
$81,079,000
$78,117,000
$75,562,000
$104,047,000
$105,270,000
Hydraulics Cylinders and Systems
—
$50,943,000
$55,349,000
$61,010,000
—
—
—
—
Merchandising Display
—
$35,699,000
$40,238,000
$66,096,000
$34,305,000
$26,049,000
$62,976,000
$34,532,000
Pumps
—
—
$0
$21,260,000
$33,658,000
$26,039,000
$61,450,000
$34,799,000
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.